---
figid: PMC10757641__fendo-14-1301017-g001
figtitle: G protein-coupled receptors and obesity
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10757641
filename: fendo-14-1301017-g001.jpg
figlink: /pmc/articles/PMC10757641/figure/f1/
number: F1
caption: 'G-protein coupled receptors (GPCRs) and peptides discussed. The anorexigenic
  hormones (blue) are released from various organs mostly in the gastrointestinal
  system and pancreas and modulate GPCRs leading to food intake suppression, reduced
  gastric emptying and increased energy expenditure. Inset. GPCR signaling: Balanced
  agonists activate both the G protein- and β-arrestin-dependent signaling pathway
  while biased agonists selectively activate the GPCR-dependent signaling pathway
  affecting cellular response through second messenger activation or the β-arrestin-dependent
  signaling pathway. Glucagon-like peptide-1 (GLP-1), oxyntomodulin (OXM), gastric
  inhibitory polypeptide (GIP), peptide YY (PYY), cannabinoid receptor 1 (CB1R), Leap-2
  (Liver-expressed antimicrobial peptide 2), melanocortin 4 receptor (MC4R), amylin
  receptor (AmR), 5-hydroxytryptamine receptor 2C (5-HT2CR). AgRP (Agouti-Related
  Protein), POMC (proopiomelanocortin); NTS, nucleus tractus solitarius; ARC, Arcuate
  nucleus; PVN, paraventricular nucleus.'
papertitle: G protein-coupled receptors and obesity.
reftext: Alessandro Pocai. Front Endocrinol (Lausanne). 2023;14:1301017.
year: '2023'
doi: 10.3389/fendo.2023.1301017
journal_title: Frontiers in Endocrinology
journal_nlm_ta: Front Endocrinol (Lausanne)
publisher_name: Frontiers Media S.A.
keywords: GLP-1 | GIP | semaglutide | tirzepatide | glucagon | amylin | obesity
automl_pathway: 0.9145708
figid_alias: PMC10757641__F1
figtype: Figure
redirect_from: /figures/PMC10757641__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10757641__fendo-14-1301017-g001.html
  '@type': Dataset
  description: 'G-protein coupled receptors (GPCRs) and peptides discussed. The anorexigenic
    hormones (blue) are released from various organs mostly in the gastrointestinal
    system and pancreas and modulate GPCRs leading to food intake suppression, reduced
    gastric emptying and increased energy expenditure. Inset. GPCR signaling: Balanced
    agonists activate both the G protein- and β-arrestin-dependent signaling pathway
    while biased agonists selectively activate the GPCR-dependent signaling pathway
    affecting cellular response through second messenger activation or the β-arrestin-dependent
    signaling pathway. Glucagon-like peptide-1 (GLP-1), oxyntomodulin (OXM), gastric
    inhibitory polypeptide (GIP), peptide YY (PYY), cannabinoid receptor 1 (CB1R),
    Leap-2 (Liver-expressed antimicrobial peptide 2), melanocortin 4 receptor (MC4R),
    amylin receptor (AmR), 5-hydroxytryptamine receptor 2C (5-HT2CR). AgRP (Agouti-Related
    Protein), POMC (proopiomelanocortin); NTS, nucleus tractus solitarius; ARC, Arcuate
    nucleus; PVN, paraventricular nucleus.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CNR1
  - MC4R
  - AGRP
  - GHSR
  - ARC
  - NOL3
  - GLP1R
  - GCGR
  - POMC
  - GIPR
  - HTR2C
  - NTS
  - GPR182
  - GCG
  - ZGLP1
  - PYY
  - GIP
  - GNAI2
  - C1QTNF1
  - FFAR1
  - LEAP2
  - Glucagon
  - Leap-2
---
